However, a 175 cases study by West NR et al. [37] suggested that tumor-infiltrating Foxp3+lymphocytes were linked to good clinical outcome in basal-like BC subtype, which seemingly contradicts the results of our study. The gene discussed is FOXP3; the disease is breast cancer.